Status:
UNKNOWN
Desflurane and Sevoflurane in Pediatrics With Elevated Liver Enzymes
Lead Sponsor:
National Cancer Institute, Egypt
Conditions:
Liver Functions Tests
Eligibility:
All Genders
1-12 years
Phase:
NA
Brief Summary
It is designed to compare effects of inhaled anaesthetic desflurane and sevoflurane on liver functions in pediatric cancer patients
Detailed Description
Patients will be randomly allocated into two groups using a sealed envelope technique: desflurane group (Des group, n = 30) and sevoflurane group (sevo group, n = 30). Anesthesia monitoring included ...
Eligibility Criteria
Inclusion
- Age \>1 year and \< 12 years old.
- Estimated time of surgeries within 1-3 hours.
- Elevated liver enzymes less than triple folds.
Exclusion
- Patient refusal.
- Hepatitis positive patients.
- Raising liver enzymes.
- Hepatic surgeries.
Key Trial Info
Start Date :
June 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 17 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04775212
Start Date
June 17 2021
End Date
October 17 2021
Last Update
October 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National cancer institute
Cairo, Egypt, 11769